177 related articles for article (PubMed ID: 37994967)
1. Pretreatment MRI-detected extramural venous invasion as a prognostic and predictive biomarker for neoadjuvant chemoradiotherapy in non-metastatic rectal cancer: a propensity score matched analysis.
Yang SY; Bae H; Seo N; Han K; Han YD; Cho MS; Hur H; Min BS; Kim NK; Lee KY; Lim JS
Eur Radiol; 2024 Jun; 34(6):3686-3698. PubMed ID: 37994967
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging performed before and after preoperative chemoradiotherapy in rectal cancer: predictive factors of recurrence and prognostic significance of MR-detected extramural venous invasion.
Prampolini F; Taschini S; Pecchi A; Sani F; Spallanzani A; Gelsomino F; Kaleci S; Torricelli P
Abdom Radiol (NY); 2020 Oct; 45(10):2941-2949. PubMed ID: 30483843
[TBL] [Abstract][Full Text] [Related]
3. The Predictive Value of Pre-/Postneoadjuvant Chemoradiotherapy MRI Characteristics for Patient Outcomes in Locally Advanced Rectal Cancer.
Meng Y; Wan L; Zhang C; Wang C; Ye F; Li S; Zou S; Cheng J; Xu K; Zhou C; Zhang H
Acad Radiol; 2020 Sep; 27(9):e233-e243. PubMed ID: 31780392
[TBL] [Abstract][Full Text] [Related]
4. Survival outcomes of different neoadjuvant treatment regimens in patients with locally advanced rectal cancer and MRI-detected extramural venous invasion.
Chen M; Ma Y; Song YW; Huang J; Gao YH; Zheng J; He F
Cancer Med; 2023 Nov; 12(21):20523-20537. PubMed ID: 37864414
[TBL] [Abstract][Full Text] [Related]
5. MRI features and texture analysis for the early prediction of therapeutic response to neoadjuvant chemoradiotherapy and tumor recurrence of locally advanced rectal cancer.
Park H; Kim KA; Jung JH; Rhie J; Choi SY
Eur Radiol; 2020 Aug; 30(8):4201-4211. PubMed ID: 32270317
[TBL] [Abstract][Full Text] [Related]
6. MRI-detected tumor deposits in cT3 and cT4 rectal cancer following neoadjuvant chemoradiotherapy.
Que YT; Chen Y; Yang XY; Ma YR; Liu YY; Wen ZQ; Lu BL; Wu XH; Zhang ZW; Wu YZ; Yu SP; Yuan JP
Eur Radiol; 2024 May; 34(5):2963-2973. PubMed ID: 37840101
[TBL] [Abstract][Full Text] [Related]
7. MRI morphologic and clinicopathologic characteristics for predicting outcomes in patients with locally advanced rectal cancer.
Meng Y; Wan L; Ye F; Zhang C; Zou S; Zhao X; Xu K; Zhang H; Zhou C
Abdom Radiol (NY); 2019 Nov; 44(11):3652-3663. PubMed ID: 30456561
[TBL] [Abstract][Full Text] [Related]
8. MRI-defined high-risk rectal cancer patients: outcome comparison between neoadjuvant chemoradiotherapy plus TME and TME plus adjuvant chemotherapy or TME alone.
Jia X; Xie P; Bi L; Meng X; Wang Z; Hong N; Wang Y
Br J Radiol; 2021 Apr; 94(1120):20201221. PubMed ID: 33591799
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of progression-free survival for locally advanced rectal cancer by MRI after neoadjuvant chemoradiotherapy and total mesorectal excision].
Zhang JX; Yang Z; Fan P; Zhang JJ; Xin L; Hou LN; Du XS; Yang XT
Zhonghua Zhong Liu Za Zhi; 2018 Feb; 40(2):121-126. PubMed ID: 29502372
[No Abstract] [Full Text] [Related]
10. Is neoadjuvant chemoradiotherapy always necessary for mid/high local advanced rectal cancer: A comparative analysis after propensity score matching.
Zhang Y; Sun Y; Xu Z; Chi P; Lu X
Eur J Surg Oncol; 2017 Aug; 43(8):1440-1446. PubMed ID: 28502421
[TBL] [Abstract][Full Text] [Related]
11. Low- Versus High-Risk Rectal Cancer Based on MRI Features: Outcomes in Patients Treated Without Neoadjuvant Chemoradiotherapy.
Jia XX; Wang Y; Cheng J; Yao X; Yin MJ; Zhou J; Ye YJ
AJR Am J Roentgenol; 2018 Aug; 211(2):327-334. PubMed ID: 29927331
[TBL] [Abstract][Full Text] [Related]
12. MRI-based EMVI positivity predicts systemic recurrence in rectal cancer patients with a good tumor response to chemoradiotherapy followed by surgery.
Cho MS; Park YY; Yoon J; Yang SY; Baik SH; Lee KY; Kim IY; Kim NK
J Surg Oncol; 2018 Jun; 117(8):1823-1832. PubMed ID: 29790177
[TBL] [Abstract][Full Text] [Related]
13. Predicting prognosis according to preoperative chemotherapy response in patients with locally advanced lower rectal cancer.
Shiraishi T; Sasaki T; Ikeda K; Tsukada Y; Nishizawa Y; Ito M
BMC Cancer; 2019 Dec; 19(1):1222. PubMed ID: 31842797
[TBL] [Abstract][Full Text] [Related]
14. Perineural Invasion Predicts for Distant Metastasis in Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiation and Surgery.
Chablani P; Nguyen P; Pan X; Robinson A; Walston S; Wu C; Frankel WL; Chen W; Bekaii-Saab T; Chakravarti A; Wuthrick E; Williams TM
Am J Clin Oncol; 2017 Dec; 40(6):561-568. PubMed ID: 26703815
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
[No Abstract] [Full Text] [Related]
16. Improved Metastasis- and Disease-Free Survival With Preoperative Sequential Short-Course Radiation Therapy and FOLFOX Chemotherapy for Rectal Cancer Compared With Neoadjuvant Long-Course Chemoradiotherapy: Results of a Matched Pair Analysis.
Markovina S; Youssef F; Roy A; Aggarwal S; Khwaja S; DeWees T; Tan B; Hunt S; Myerson RJ; Chang DT; Parikh PJ; Olsen JR
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):417-426. PubMed ID: 28871992
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy may improve disease-free survival in patients with rectal cancer positive for MRI-detected extramural venous invasion following chemoradiation.
Chand M; Rasheed S; Heald R; Swift I; West N; Rao S; Tekkis P; Brown G
Colorectal Dis; 2017 Jun; 19(6):537-543. PubMed ID: 27673438
[TBL] [Abstract][Full Text] [Related]
18. Prognostic risk factors and survival models for T3 locally advanced rectal cancer: what can we learn from the baseline MRI?
Zhao Q; Wan L; Zou S; Zhang C; E T; Yang Y; Ye F; Zhao X; Ouyang H; Zhang H
Eur Radiol; 2021 Jul; 31(7):4739-4750. PubMed ID: 34003351
[TBL] [Abstract][Full Text] [Related]
19. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging-Defined Extramural Venous Invasion Predicts Distant Metastasis and Reflects Strong Tumor Invasiveness in Rectal Cancer.
Matsunaka T; Goi T; Kurebayashi H; Morikawa M; Okazawa H; Tsujikawa T
Oncology; 2024; 102(2):99-106. PubMed ID: 37562361
[TBL] [Abstract][Full Text] [Related]
20. MRI-defined T3, clear mesorectal fascia mid-low rectal cancer: is neoadjuvant treatment necessary?
Zeng Z; Li Z; Luo S; Huang L; Liang Z; Zheng X; Li W; Xiong L; Liu H; Kang L
J Gastroenterol Hepatol; 2024 May; 39(5):858-867. PubMed ID: 38225773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]